India: Pharmaceutical

Publication Date	June 2008
Publisher	ISI Emerging Markets
Product Type	Report
Pages	20
ISBN Number	not applicable
Product Code	ISI00024

Buy this product or for assistance call +44 20 7060 7474

PDF £405.00$674 | €453

PRINT £405.00$674 | €453

CD-ROM £405.00$674 | €453

OTHER£405.00$674 | €453

FAX Order above formats by FAX

Summary

India: Pharmaceutical covers the sector overview of the pharmaceutical industry in India, the size and value of the generic market, drug master file (DMF) filings, US FDA approved manufacturing plants, and the sector performance in production and export. It also covers the new patent law, regulatory changes, R&D spending, generic opportunities, contract research and manufacturing (CRAM), market trends and outlook, plus the profile, comparative matrix and SWOT analysis of the industry leading players:

Dr.Reddy's Laboratories, Ranbaxy Laboratories, Cipla, Sun Pharmaceutical and Workhardt.

Content

1. Industry Profile
- 1.1 Sector Overview
- 1.2 Sector Size and Value
  - 1.2.1 Generic Market
  - 1.2.2 Drug Master File (DMF) Filings
  - 1.2.3 US FDA Approved Manufacturing Plants
- 1.3 Sector Performance
  - 1.3.1 Pharmaceutical Production
  - 1.3.2 Pharmaceutical Export
2. Market Trends and Outlook
- 2.1 New Patent Law
- 2.2 Regulatory Changes
- 2.3 R&D Spending
- 2.4 Exploiting Generic Opportunities
- 2.5 Contract Research and Manufacturing (CRAM)
3. Leading Players and Comparative Matrix
- 3.1 Leading Players
  - 3.1.1 Dr. Reddys Laboratories
  - 3.1.2 Ranbaxy Laboratories
  - 3.1.3 Cipla
  - 3.1.4 Sun Pharmaceutical
  - 3.1.5 Wockhardt
- 3.2 Comparative Matrix
- 3.3 SWOT Analysis

Delivery Details

PDF:Immediate delivery

PRINT/CD-ROM:

Ask a question about this product

Need help finding the right product?

Product features / use

Scope	Comprehensive Overview
Level	General Industry Strategies
Data	Broad Market Predictions
Profiles	Profiles of Key Companies
Features	Contains SWOT Analysis